**Core Concept**
Methamoglobinemia is a condition characterized by an abnormal increase in methemoglobin levels in the blood, which can lead to tissue hypoxia. Certain local anesthetics can induce methemoglobinemia by releasing nitric oxide, which then oxidizes hemoglobin to methemoglobin.

**Why the Correct Answer is Right**
Prilocaine is a local anesthetic that has the potential to cause methemoglobinemia due to its metabolite, o-toluidine, which is a potent oxidizing agent. When prilocaine is metabolized, o-toluidine is released, and it can oxidize hemoglobin to methemoglobin, leading to tissue hypoxia. This is a dose-dependent effect, and patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency are more susceptible to methemoglobinemia.

**Why Each Wrong Option is Incorrect**
**Option A:** Lidocaine is a widely used local anesthetic, but it does not have the potential to cause methemoglobinemia. Lidocaine is metabolized by liver enzymes, and its metabolites do not have oxidizing properties.

**Option B:** Bupivacaine is another local anesthetic that can cause systemic toxicity, but it is not associated with methemoglobinemia. Bupivacaine's toxicity profile is primarily related to its effects on the cardiovascular and central nervous systems.

**Option C:** Articaine is a local anesthetic that is used for dental procedures, but it is not known to cause methemoglobinemia. Articaine's metabolism does not involve the release of o-toluidine or other oxidizing agents.

**Clinical Pearl / High-Yield Fact**
When using prilocaine, monitor patients closely for signs of methemoglobinemia, such as cyanosis, tachycardia, and dyspnea. If methemoglobinemia is suspected, discontinue the local anesthetic and administer methylene blue to reduce methemoglobin levels.

**Correct Answer: C. Articaine is not known to cause methamoglobinemia.